Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...

Eli Lilly's Mounjaro drug to be added to China's health insurance scheme for type 2 diabetes patients, potentially impacting ...

Potatoes have long gotten a bad rap for raising blood sugar levels. But it turns out the spud's cooking method may make a ...

The device is the first diabetic monitoring system built specifically for veterinary use on these animals, said ALR ...

Four years later Gardell credits his surgeon Dr. Philippe Quilici and nutritionist Teri Hlubik with making his transformation ...

Continuous glucose monitoring (CGM) is underutilized in non-insulin-treated type 2 diabetes (T2D) despite evidence of ...

Sansum Diabetes Research Institute (SDRI) has opened a free walk-in screening clinic to help community members understand their risk for type 1 diabetes ...

Objectives We hypothesise that women with type 2 diabetes and hypertension are less likely than comparable men to receive renin–angiotensin system (RAS)-inhibiting antihypertensive treatment, ...

Launch targets $16 billion SGLT-2 inhibitor market that serves 33 million type II diabetics in the US, many of whom are uninsured and underinsured and whose out-of-pocket costs exceed Brenzavvy‘s cash ...

An international research team led by Professor Marc-Emmanuel Dumas at Imperial College London & CNRS together with Prof.

Abbott Laboratories (NYSE: ABT) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two fundamentally ...

Adults with a normal BMI can still face heart risks from excess abdominal fat. New research shows why waist size deserves ...